ULF received donations in memorial or honorarium for the following during the month of October 2023. We apologize for any inadvertent omittance or misspellings. Please notify us if we have made a mistake at office@ulf.org or by calling 815-748-3211. In Honor of Zane Dial Sandra Dial Michael Dial Sofia Jan Ainger Sam Buck Anonymous Support […]
In Memorial and Honor – October 2023 Read More »
The ULF is happy to share this press release on behalf of Minoryx regarding their CALYX Trial for patients affected by cALD. Here is a preview but click the link below to read the full press release. “Minoryx Therapeutics, a registration stage biotech company focused on the development of therapies for orphan central nervous system
Minoryx Announces Patient Enrollment of their CALYX Trial Read More »
The ULF is happy to share a community letter from Vigil regarding their potential treatment option for those affected by ALSP! Here is a preview but click the links below to read the whole letter and press release. “Dear ALSP Community Members: This week we announced positive interim data from IGNITE, our Phase 2 clinical
Vigil Neuro: ALSP Community Letter Read More »
